ID24174A - Vector dari porcine adenovirus - Google Patents

Vector dari porcine adenovirus

Info

Publication number: ID24174A
Authority: ID; Indonesia
Prior art keywords: porcine adenovirus; recombinant; vector; nucleotide sequence; methods
Prior art date: 1997-08-14

Application number

IDW20000491A

Other languages

English (en)

Inventor

Michael Johnson

J M Hammond

Original Assignee

Commw Scient Ind Res Org

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-08-14

Filing date

1998-08-14

Publication date

2000-07-13

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3802849&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID24174(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-08-14 Application filed by Commw Scient Ind Res Org filed Critical Commw Scient Ind Res Org

2000-07-13 Publication of ID24174A publication Critical patent/ID24174A/id

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/235—Adenoviridae
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
- C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Biophysics (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Immunology (AREA)
Virology (AREA)
Bioinformatics & Cheminformatics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biotechnology (AREA)
Wood Science & Technology (AREA)
Gastroenterology & Hepatology (AREA)
General Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Microbiology (AREA)
Physics & Mathematics (AREA)
Chemical Kinetics & Catalysis (AREA)
Plant Pathology (AREA)
Toxicology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

IDW20000491A 1997-08-14 1998-08-14 Vector dari porcine adenovirus ID24174A (id)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
AUPO8560A AUPO856097A0 (en)	1997-08-14	1997-08-14	Vector

Publications (1)

Publication Number	Publication Date
ID24174A true ID24174A (id)	2000-07-13

Family

ID=3802849

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDW20000491A ID24174A (id)	1997-08-14	1998-08-14	Vector dari porcine adenovirus

Country Status (18)

Country	Link
US (3)	US7323177B1 (id)
EP (2)	EP1825863A1 (id)
JP (2)	JP4365023B2 (id)
KR (1)	KR100746524B1 (id)
CN (1)	CN100366292C (id)
AT (1)	ATE357250T1 (id)
AU (2)	AUPO856097A0 (id)
BR (1)	BR9811184A (id)
CY (1)	CY1106565T1 (id)
DE (1)	DE69837390T2 (id)
DK (1)	DK1007088T3 (id)
ES (1)	ES2283068T3 (id)
HK (1)	HK1032755A1 (id)
ID (1)	ID24174A (id)
MX (1)	MXPA00001562A (id)
NZ (1)	NZ503039A (id)
PT (1)	PT1007088E (id)
WO (1)	WO1999008706A1 (id)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AUPO856097A0 (en) *	1997-08-14	1997-09-04	Commonwealth Scientific And Industrial Research Organisation	Vector
US6492343B1 (en)	1998-04-15	2002-12-10	University Of Saskatchewan	Porcine adenovirus type 3 genome
FR2789695B1 (fr) *	1999-02-11	2003-03-07	Merial Sas	Vecteurs et vaccins viraux a base d'adenovirus porcins recombines et replicatifs
FR2804028B1 (fr) *	2000-01-21	2004-06-04	Merial Sas	Vaccins adn ameliores pour animaux de rente
CA2413265A1 (en) *	2000-05-03	2001-11-08	University Of Guelph	Porcine adenovirus type 5 vector and vaccine
AU2002211654A1 (en) *	2000-10-10	2002-04-22	Genstar Therapeutics	Minimal adenoviral vector and recombinant vaccines based thereon
CZ304525B6 (cs)	2001-03-27	2014-06-18	University Of Saskatchewan	Způsob kultivace circoviru
WO2003013598A2 (en) *	2001-08-09	2003-02-20	Lam Dominic M K	Novel vaccine compositions and methods of vaccine preparation for veterinary and human diseases
US7045335B2 (en)	2001-09-06	2006-05-16	Alphavax, Inc.	Alphavirus replicon vector systems
JP3949520B2 (ja) *	2001-09-20	2007-07-25	独立行政法人科学技術振興機構	レギュカルチン過剰発現モデル動物
US7569217B2 (en)	2001-09-24	2009-08-04	University Of Saskatchewan	Porcine adenovirus E1 and E4 regions
KR20030054139A (ko) *	2001-12-24	2003-07-02	학교법인 건국대학교	돼지 오제스키병 바이러스의 ｇＤ 유전자를 포함하는재조합 발현 벡터 및 이를 이용한 ＤＮＡ 백신
US7906311B2 (en)	2002-03-20	2011-03-15	Merial Limited	Cotton rat lung cells for virus culture
DK3246399T3 (da)	2002-12-13	2021-10-04	Alphavax Inc	Alfavirus-partikler og fremgangsmåder til fremstilling
WO2004055166A2 (en)	2002-12-13	2004-07-01	Alphavax, Inc.	Multi-antigenic alphavirus replicon particles and methods
AU2004223477B2 (en)	2003-03-20	2009-03-26	Alphavax, Inc.	Improved alphavirus replicons and helper constructs
ATE432285T1 (de)	2003-07-11	2009-06-15	Alphavax Inc	Cytomegalovirusimpfstoffe, die auf dem alphavirus basieren
DE602005012382D1 (de)	2004-05-18	2009-03-05	Alphavax Inc	Von tc-83 abgeleitete alphavirus-vektoren, partikel und verfahren
RU2389506C2 (ru) *	2005-09-09	2010-05-20	Интервет Интернэшнл Б.В.	Вакцина против рсv-2
JP2009544303A (ja) *	2006-07-28	2009-12-17	コモンウェルスサイエンティフィックアンドインダストリアルリサーチオーガニゼイション	組換え型アデノウイルスベクターの組織親和性を増大させるための方法および組成物
CA2689588C (en)	2007-06-21	2016-08-23	Alphavax, Inc.	Promoterless cassettes for expression of alphavirus structural proteins
US20100150959A1 (en) *	2008-12-15	2010-06-17	Vectogen Pty Ltd.	PCV 2-Based Methods and Compositions for the Treatment of Pigs
US20110135688A1 (en) *	2009-12-04	2011-06-09	Michael Sheppard	Methods and Compositions for Increasing Titer of Recombinant Porcine Adenovirus-3 Vectors
MX2014013964A (es) *	2012-05-17	2015-03-04	Zoetis Llc	Vacunacion eficaz contral el virus del sindrome reproductivo y respiratorio porcino (prrs) antes del destete.
EA033248B1 (ru) *	2014-02-20	2019-09-30	Вэксарт, Инк.	Композиция и способ индукции иммунного ответа
KR20190085977A (ko)	2016-12-14	2019-07-19	조에티스 서비시즈 엘엘씨	젖떼기 전, 유럽의 돼지 생식기 및 호흡기 증후군 (prrs) 균주 바이러스에 대한 효과적인 백신접종
CN110904127B (zh) *	2018-09-18	2024-09-20	瓦赫宁恩研究基金会	非洲猪瘟病毒疫苗

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4320068C1 (de)	1993-06-17	1994-12-15	Audi Ag	Verfahren und Vorrichtung zur Reparatur von Fahrzeugkarosserien aus Leichtmetallteilen
CN1115414C (zh) *	1993-07-13	2003-07-23	罗纳-布朗克罗莱尔股份有限公司	用于基因治疗的病毒载体
BR9508224A (pt)	1994-07-14	1997-10-28	Union Camp Patent Holding	Processo tendo seletividade aumentada para alvejamento de polpa lignocelulósica alvejada
FR2725213B1 (fr)	1994-10-04	1996-11-08	Rhone Poulenc Rorer Sa	Vecteurs viraux et utilisation en therapie genique
ES2105984B1 (es)	1995-11-30	1998-04-16	Iberica Cyanamid	Adenovirus recombinantes que expresan antigenos del virus de la gastroenteritis porcina transmisible (vgpt) y su empleo en la formacion de vacunas.
AUPO856097A0 (en) *	1997-08-14	1997-09-04	Commonwealth Scientific And Industrial Research Organisation	Vector
US6492343B1 (en)	1998-04-15	2002-12-10	University Of Saskatchewan	Porcine adenovirus type 3 genome

1997
- 1997-08-14 AU AUPO8560A patent/AUPO856097A0/en not_active Abandoned
1998
- 1998-08-14 JP JP2000509443A patent/JP4365023B2/ja not_active Expired - Fee Related
- 1998-08-14 EP EP07005454A patent/EP1825863A1/en not_active Withdrawn
- 1998-08-14 CN CNB98809116XA patent/CN100366292C/zh not_active Expired - Fee Related
- 1998-08-14 DK DK98938527T patent/DK1007088T3/da active
- 1998-08-14 BR BR9811184-1A patent/BR9811184A/pt not_active IP Right Cessation
- 1998-08-14 MX MXPA00001562A patent/MXPA00001562A/es active IP Right Grant
- 1998-08-14 US US09/485,512 patent/US7323177B1/en not_active Expired - Fee Related
- 1998-08-14 ID IDW20000491A patent/ID24174A/id unknown
- 1998-08-14 ES ES98938527T patent/ES2283068T3/es not_active Expired - Lifetime
- 1998-08-14 DE DE69837390T patent/DE69837390T2/de not_active Expired - Lifetime
- 1998-08-14 NZ NZ503039A patent/NZ503039A/xx not_active IP Right Cessation
- 1998-08-14 EP EP98938527A patent/EP1007088B1/en not_active Expired - Lifetime
- 1998-08-14 PT PT98938527T patent/PT1007088E/pt unknown
- 1998-08-14 KR KR1020007001486A patent/KR100746524B1/ko not_active IP Right Cessation
- 1998-08-14 AT AT98938527T patent/ATE357250T1/de active
- 1998-08-14 WO PCT/AU1998/000648 patent/WO1999008706A1/en active IP Right Grant
2001
- 2001-05-22 HK HK01103506A patent/HK1032755A1/xx not_active IP Right Cessation
2006
- 2006-03-22 US US11/387,026 patent/US7473428B2/en not_active Expired - Fee Related
2007
- 2007-05-07 CY CY20071100603T patent/CY1106565T1/el unknown
2008
- 2008-08-22 US US12/197,056 patent/US7785602B2/en not_active Expired - Fee Related
2009
- 2009-07-01 JP JP2009156467A patent/JP2009213495A/ja active Pending
2011
- 2011-09-09 AU AU2011224111A patent/AU2011224111A1/en not_active Ceased

Also Published As

Publication number	Publication date
DE69837390T2 (de)	2007-08-23
EP1007088A4 (en)	2003-01-08
KR20010022882A (ko)	2001-03-26
ATE357250T1 (de)	2007-04-15
HK1032755A1 (en)	2001-08-03
PT1007088E (pt)	2007-05-31
JP2009213495A (ja)	2009-09-24
DE69837390D1 (de)	2007-05-03
US7785602B2 (en)	2010-08-31
US20060263387A1 (en)	2006-11-23
JP4365023B2 (ja)	2009-11-18
AUPO856097A0 (en)	1997-09-04
ES2283068T3 (es)	2007-10-16
WO1999008706A8 (en)	2000-08-10
KR100746524B1 (ko)	2007-08-07
NZ503039A (en)	2002-09-27
MXPA00001562A (es)	2004-10-14
US7473428B2 (en)	2009-01-06
EP1825863A1 (en)	2007-08-29
BR9811184A (pt)	2001-12-26
EP1007088B1 (en)	2007-03-21
US7323177B1 (en)	2008-01-29
JP2001514871A (ja)	2001-09-18
CN1275084A (zh)	2000-11-29
CY1106565T1 (el)	2012-01-25
CN100366292C (zh)	2008-02-06
US20090226485A1 (en)	2009-09-10
EP1007088A1 (en)	2000-06-14
DK1007088T3 (da)	2007-06-04
WO1999008706A1 (en)	1999-02-25
AU2011224111A1 (en)	2011-10-13

Publication	Publication Date	Title
ID24174A (id)	2000-07-13	Vector dari porcine adenovirus
DE69632235D1 (de)	2004-05-27	Newcastle-Krankheitsvirus-Kombinationsimpfstoff
ATE292685T1 (de)	2005-04-15	Herstellung und verwendung von rekombinanten influenza a virus m2 konstruktionen und impstoffe
AU9063801A (en)	2002-03-22	Methods and compositions for diseases associated with amyloidosis
NO20001768L (no)	2000-06-02	Viruskapsomervaksine, fremgangsmÕte til fremstilling samt anvendelse derav
CY1107570T1 (el)	2013-03-13	Ανοσογονικα πολυπεπτιδια κωδικοποιουμενα απο μινιγονιδια mage και οι χρησεις τους
WO2001089559A3 (en)	2002-04-11	Porcine reproductive and respiratory syndrome virus (prrsv) recombinant avipoxvirus vaccine
BR9708401A (pt)	2000-01-04	Vetores de vìrus de para-varìola
ATE104349T1 (de)	1994-04-15	Vakzine gegen coccidiose.
DE69738641D1 (de)	2008-05-29	Lebend-impfstoff gegen heliobacter pylori
EP0236977A3 (en)	1989-05-03	Bovine virus diarrhea and hog cholera vaccines
NL300336I2 (nl)	2009-01-05	Vaccin tegen de bof dat een jeryl-lynn virusstam bevat
BR0007855A (pt)	2001-10-23	Vacina de vìrus eliminado o gene bhv-1
FI953371A (fi)	1996-01-09	TBE-virusinfektiota vastaan tähtäävään immunisointiin tarkoitetut parannetut rokotteet sekä menetelmä niiden valmistamiseksi
GR3029665T3 (en)	1999-06-30	16 kDa SURFACE PROTEIN OF -i(P. FALCIPARUM).
BR9508645B1 (pt)	2009-01-13	seqÜÊncia de nucleotÍdeos isolada compreendendo o gene s fipv tendo uma seqÜencia de nucleotÍdeos da cepa 79-1146 fipv, bem como polipeptÍdeo, vacina e composiÇço compreendendo a mesma.
WO2000074630A3 (en)	2002-06-06	Dna vaccine for protecting an avian against infectious bursal disease virus
NZ227943A (en)	1991-08-27	An antigen derived from the neck region of the rhoptries of merozoites and vaccine against plasmodium falciparum
ZA906667B (en)	1991-06-26	Antigens and polypeptides derived from babesia(12d3 antigen)